The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib

被引：0
|
作者：
Francesco Grossi
Erika Rijavec
Maria Giovanna Dal Bello
Carlotta Defferrari
Annalisa Brianti
Giulia Barletta
Carlo Genova
Carmelina Murolo
Maurizio Cosso
Gabriella Fontanini
Laura Boldrini
Mauro Truini
Paolo Pronzato
机构：
[1] Istituto Nazionale per la Ricerca sul Cancro,S.S. Tumori Polmonari
[2] Istituto Nazionale per la Ricerca sul Cancro,S.C. Diagnostica per immagini ed interventistica oncologica
[3] Dipartimento di Chirurgia Università di Pisa,Sezione Anatomia Patologica
[4] Istituto Nazionale per la Ricerca sul Cancro,S.C. Anatomia e Citoistologia patologica
[5] Istituto Nazionale per la Ricerca sul Cancro,S.C. Oncologia Medica A
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Non-small-cell lung cancer; Gefitinib; Erlotinib; EGFR-TKI toxicity; EGFR mutation; K-ras mutation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1407 / 1412
页数：5
相关论文
共 50 条
  • [21] Gefitinib for Chinese patients with advanced non-small-cell lung cancer
    Xiaotong, Z
    Longyun, L
    Xinlin, MU
    LUNG CANCER, 2004, 45 : S79 - S79
  • [22] Gefitinib (G) treatment outcome after progression on erlotinib (E) in patients with advanced non-small-cell lung cancer (NSCLC)
    Defferrari, C.
    Brianti, A.
    Dal Bello, M. G.
    Loprevite, M.
    Catania, G.
    Pronzato, P.
    Grossi, F.
    ANNALS OF ONCOLOGY, 2007, 18 : 24 - 24
  • [23] Phase II study of erlotinib as a salvage treatment for non-small-cell lung cancer patients after failure of gefitinib treatment
    Lee, D. H.
    Kim, S. -W.
    Suh, C.
    Yoon, D. H.
    Yi, E. J.
    Lee, J. -S.
    ANNALS OF ONCOLOGY, 2008, 19 (12) : 2039 - 2042
  • [24] Erlotinib as a salvage treatment after gefitinib failure for advanced non-small-cell lung cancer patients with brain metastasis A successful case report and review
    Dong, Yong
    Li, Qijun
    Miao, Qian
    Li, Da
    MEDICINE, 2021, 100 (25) : E26450
  • [25] Case 2. Response to erlotinib after failure of gefitinib in a patient with advanced non-small-cell lung carcinoma
    Garfield, DH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) : 7738 - 7740
  • [26] CT findings in non-small-cell lung cancer patients treated with gefitinib or erlotinib
    Na, Im Il
    Choe, Du Hwan
    Kim, Cheol Hyeon
    Park, Sun Hoo
    Park, Jong Heon
    Lee, Jae Cheol
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2012, 8 (02) : 247 - 253
  • [27] THE THERAPEUTIC OUTCOMES OF ERLOTINIB AFTER FAILURE OF GEFITINIB FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Matsunami, Keiji
    Matsumoto, Shingo
    Suyama, Hisashi
    Kodani, Masahiro
    Toge, Hirokazu
    Kawasaki, Yuji
    Igishi, Tadashi
    Nakamura, Hiroshige
    Shimizu, Eiji
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1241 - S1241
  • [28] Gefitinib in the treatment of advanced non-small-cell lung cancer
    Reck, Martin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (04) : 401 - 412
  • [29] Gefitinib for refractory advanced non-small-cell lung cancer
    Moriguchi, H
    Kim, TY
    Sato, C
    LANCET, 2006, 367 (9507): : 299 - 300
  • [30] Gefitinib therapy for advanced non-small-cell lung cancer
    Liu, CY
    Seen, S
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (11) : 1644 - 1653
12345